TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 4 | -1 | 1 | 11 | 33 | 44 | 22 | 18 |
P | %wins | 25 | 50 | 75 | 100 | 75 | 75 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/3/14 16:48 | 12/3/14 | VRX | Valeant Pharmaceuticals International, Inc. | A8 | Health | Drug | Pharmaceutical Preparations | Stevenson Katharine Berghuis | A8 | D | P | 219 | 145.73 | 33 | 2 | 7 | 23 | D | 165 | 33 | 14 | 23 | 12 | 13 | 3 | 1 | -1 | -3 | -1 | 40 | 60 | -34 | |
8/9/11 17:03 | 8/8/11 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Stevenson Katharine Berghuis | A6 | D | P | 40 | 39.73 | 33 | 1 | 11 | 10 | D | 191 | 73 | -4 | -26 | -25 | -31 | -31 | -27 | -5 | -1 | 10 | 10 | 25 | 24 | |
3/16/11 12:23 | 3/14/11 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Stevenson Katharine Berghuis | A6 | D | P | 81 | 40.59 | 33 | 2 | 67 | 5 | D | 272 | 168 | 55 | 40 | 3 | 4 | 1 | 2 | -2 | 5 | 31 | 34 | -1 | 34 | |
12/1/10 17:07 | 11/29/10 | VRX | Valeant Pharmaceuticals International, Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Stevenson Katharine Berghuis | A6 | D | P | 76 | 25.33 | 33 | 3 | New | 3 | D | 253 | 90 | 82 | 18 | 3 | 4 | 4 | 1 | 3 | 4 | 5 | 48 | 91 | 65 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |